Childhood Burkitt Lymphoma
📧 Sign up to get email alerts when something new happens for Childhood Burkitt Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of oxaliplatin, ifosfamide, and etoposide in young patients with recurrent or refractory solid tumors or lymphomas; the trial …
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma [Phase 1]
This phase 1 trial assessed safety and preliminary activity of the HDAC inhibitor vorinostat combined with bortezomib in pediatric patients …
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas [Phase 1]
Phase 1 study of oxaliplatin with irinotecan in pediatric patients with refractory solid tumors or lymphomas has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial of ispinesib in young patients with relapsed or refractory solid tumors and lymphoma has completed.